BiVictriX is a UK-based oncology-focused biotech company founded to exploit the Bi-Cygni technology, enabling the discovery and development of a new class of bispecific bio-therapeutics with improved potency and enhanced therapeutic index. Monospecific bio-therapeutics targeting a single antigen have shown considerable therapeutic benefit in a number of cancer indications. However the application of these drugs is currently limited by the widespread expression of these targets on healthy tissues, leading to often debilitating and sometimes fatal, on-target off-tissue toxicities. This lack of true cancer specificity has resulted in many targeted bio-therapeutics being removed from clinical trials and is one of the major factors limiting the development of this otherwise promising therapeutic class. BiVictriX's Bi-Cygni therapeutics are engineered to selectively target a unique cancer-restricted antigen co-expression pattern, absent from healthy cells. The Bi-Cygni technology links to the Company's in-house panel of cancer-restricted antigen combinations to generate the next generation of bispecific therapeutics with enhanced therapeutic index, across a broad range of malignant indications. The Company's initial focus is on the generation of Bi-Cygni Antibody Drug Conjugates (ADCs), with future plans to expand the technology to other therapeutic modalities (Cell engagers and CAR-T).
Alderley Edge, Cheshire, United Kingdom
Find 23 technologies across 12 categories used by BiVictriX Therapeutics Ltd
Find rich insights on prospects from BiVictriX Therapeutics Ltd including contact information, interests,skills and more
We don't have enough content for BiVictriX Therapeutics Ltd employees.
Find recent and open job postings from BiVictriX Therapeutics Ltd
We don't have enough content for BiVictriX Therapeutics Ltd jobs.
Get news, alerts, and updates about BiVictriX Therapeutics Ltd
BiVictriX Therapeutics plc, an emerging biotechnology company that develops new cancer therapies, raised Â£7.5m ahead of its IPO today.
The official website of BiVictriX Therapeutics Ltd is http://www.bivictrix.com/.
Slintel keeps track of 1-10 employees who are working at BiVictriX Therapeutics Ltd.
BiVictriX Therapeutics Ltd is in the industry of Biotechnology.
The top technologies used by BiVictriX Therapeutics Ltd are :- GoDaddy DNS Vimeo Microsoft Office 365 Github Embedly Wix Answers .
BiVictriX Therapeutics Ltd headquarters are at Alderley Edge, Cheshire, United Kingdom.
BiVictriX Therapeutics Ltd's product and services are Drug Discovery Oncology Haematological Malignancy Bispecific ADC Therapeutics biotherapeutics .